The Role of Fat-Free Mass Index in Evaluating Protein-Energy Wasting in Maintenance Hemodialysis Patients: A Multicenter Cross-Sectional Study

Why It Matters

Early detection of muscle loss enables timely nutritional interventions, which can reduce morbidity and mortality in dialysis patients. Adding an objective, non‑invasive FFMI measure addresses the shortcomings of albumin, BMI and subjective assessments.

Key Takeaways

• Low FFMI found in 38.6% of hemodialysis patients.
• FFMI missed by albumin in 38.7% of normal cases.
• FFMI identified low muscle mass in 31.4% of normal BMI patients.
• FFMI correlated strongly with weight, BMI, MAC, and handgrip strength.
• Agreement between FFMI and conventional tools ranged from fair to moderate.

Pulse Analysis

Protein‑energy wasting (PEW) remains a leading cause of poor outcomes in maintenance hemodialysis patients, yet its detection is hampered by reliance on serum albumin, body‑mass index and subjective screening tools. These measures often overlook loss of lean tissue because albumin is influenced by inflammation and fluid shifts, while BMI conflates fat, muscle and water. International guidelines therefore call for more precise, objective assessments of muscle mass, but many dialysis centers lack easy‑to‑implement solutions.

In a multicenter cross‑sectional study of 272 Chinese MHD patients, FFMI derived from a multifrequency BIA device identified low muscle mass in 38.6% of the cohort. Notably, FFMI uncovered hidden muscle depletion in 38.7% of patients with normal albumin, 31.4% with normal BMI, and roughly a quarter of those deemed low‑risk by NRS2002 or SGA. Correlation analyses revealed strong links between FFMI and weight, BMI, mid‑arm circumference, mid‑arm muscle circumference, and hand‑grip strength, confirming its validity as a surrogate for skeletal muscle. Agreement with conventional tools ranged from fair to moderate, underscoring the complementary nature of FFMI.

Integrating BIA‑based FFMI into routine dialysis care offers a non‑invasive, cost‑effective way to flag patients who would otherwise be missed by standard assessments. Early identification enables clinicians to initiate targeted nutritional and exercise interventions, potentially slowing sarcopenia progression and improving survival. Future research should explore longitudinal FFMI monitoring to predict outcomes and refine intervention thresholds, positioning FFMI as a cornerstone of personalized nutrition management in renal care.